Cours actuels de Neuphoria Therapeutics Inc. - Common Stock

Bourse	Ticker	Devise	Dernier échange	Cours	Variation journalière
NASDAQ	NEUP	USD	12.06.2025 19:59	7,14 USD	7,15 USD -0,14 %

Performance

Day	Week	Month	3 Months	6 Months	1 Year	5 Years
-0,14 %	2,00 %	42,51 %	41,38 %	134,87 %	134,87 %	134,87 %

Company Profile for Neuphoria Therapeutics Inc. - Common Stock Share

Neuphoria Therapeutics, Inc. is a clinical-stage biotechnology company dedicated to developing therapies that address the complex needs of individuals affected by neuropsychiatric disorders. The company was founded on December 23, 2024 and is headquartered in Burlington, MA.

Company Data

Name Neuphoria Therapeutics Inc. - Common Stock

Company Neuphoria Therapeutics Inc.

Symbol NEUP

Website http://www.neuphoriatx.com

Primary Exchange

NASDAQ

ISIN US64136E1029

Asset Class Share

Sector Healthcare

Industry Medical - Pharmaceuticals

CEO Dr. Spyridon Papapetropoulos M.D., Ph.D.

Country United States of America

Currency USD

Employees 0,0 T

Address , Burlington

IPO Date 2021-12-16

ID Changes

Date	From	To
24.12.2024	BNOX	NEUP

Ticker Symbols

Name	Symbol
NASDAQ	NEUP

More Shares

Investors who Neuphoria Therapeutics Inc. - Common Stock hold also have the following shares in their portfolio:

BAZALGETTE FINANCE PLC 0.954% IDX-LKD BDS 15/06/54 Bond

M3 METALS CORP Share

The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.

Imprint Data Protection Blog Community Feedback Changelog